Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin

Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and l-citrulline formation

Kurt Schmidt, Jens Martens-Lobenhoffer, Andreas Meinitzer, Wolfgang F. Graier, Christina M. Torres, Richard C Venema, Bernd Mayer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The benzoquinone derivative embelin is a multifunctional drug that not only induces apoptosis by inhibiting XIAP, the X chromosome-linked inhibitor of apoptosis protein, but also blocks nuclear factor-κB signaling pathways, thereby leading to down-regulation of a variety of gene products involved in tumor cell survival, proliferation, invasion, angiogenesis, and inflammation. Here, we report that embelin activates and modulates l-arginine/nitric oxide/cyclic GMP signaling in cultured endothelial cells. Embelin elicited a rapid increase of intracellular free Ca 2+ , leading to activation of endothelial nitric oxide synthase (eNOS) and NO-induced cGMP accumulation. While the cGMP response was comparable to that caused by other Ca 2+ -mobilizing agents, the stimulatory effect of embelin on l-citrulline formation (∼4-fold) was substantially lower than that observed upon activation of eNOS with the Ca 2+ ionophore A23187 (∼18-fold), the receptor agonist ATP (∼16-fold) or the sarco-endoplasmic reticulum Ca 2+ -ATPase inhibitor thapsigargin (∼14-fold). The apparent discrepancy between NO/cGMP and l-citrulline formation in embelin-treated cells was not due to enhanced metabolism and/or efflux of l-citrulline, increased NO bioavailability, inhibition of cGMP hydrolysis, sensitization of soluble guanylate cyclase (sGC) to NO, or enhanced formation of a sGC/eNOS complex. Our puzzling observations suggest that embelin improves coupling of endothelial NO synthesis to sGC activation through mobilization of an as yet unrecognized signaling pathway.

Original languageEnglish (US)
Pages (from-to)281-289
Number of pages9
JournalNitric Oxide - Biology and Chemistry
Volume22
Issue number4
DOIs
StatePublished - May 15 2010

Fingerprint

Citrulline
Nitric Oxide Synthase Type III
Cyclic GMP
Prodrugs
Nitric Oxide
Chemical activation
Guanylate Cyclase
Pharmaceutical Preparations
X-Linked Inhibitor of Apoptosis Protein
Inhibitor of Apoptosis Proteins
Purinergic P2 Receptors
Thapsigargin
Ionophores
Endothelial cells
Calcimycin
Cell proliferation
X Chromosome
Chromosomes
Metabolism
Endoplasmic Reticulum

Keywords

  • Embelin
  • Endothelial nitric oxide synthase
  • Nitric oxide
  • Soluble guanylate cyclase
  • cGMP
  • l-Citrulline

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Clinical Biochemistry
  • Cancer Research

Cite this

Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin : Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and l-citrulline formation. / Schmidt, Kurt; Martens-Lobenhoffer, Jens; Meinitzer, Andreas; Graier, Wolfgang F.; Torres, Christina M.; Venema, Richard C; Mayer, Bernd.

In: Nitric Oxide - Biology and Chemistry, Vol. 22, No. 4, 15.05.2010, p. 281-289.

Research output: Contribution to journalArticle

Schmidt, Kurt ; Martens-Lobenhoffer, Jens ; Meinitzer, Andreas ; Graier, Wolfgang F. ; Torres, Christina M. ; Venema, Richard C ; Mayer, Bernd. / Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin : Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and l-citrulline formation. In: Nitric Oxide - Biology and Chemistry. 2010 ; Vol. 22, No. 4. pp. 281-289.
@article{382026b84d804f4da2fdf797382ed1d8,
title = "Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin: Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and l-citrulline formation",
abstract = "The benzoquinone derivative embelin is a multifunctional drug that not only induces apoptosis by inhibiting XIAP, the X chromosome-linked inhibitor of apoptosis protein, but also blocks nuclear factor-κB signaling pathways, thereby leading to down-regulation of a variety of gene products involved in tumor cell survival, proliferation, invasion, angiogenesis, and inflammation. Here, we report that embelin activates and modulates l-arginine/nitric oxide/cyclic GMP signaling in cultured endothelial cells. Embelin elicited a rapid increase of intracellular free Ca 2+ , leading to activation of endothelial nitric oxide synthase (eNOS) and NO-induced cGMP accumulation. While the cGMP response was comparable to that caused by other Ca 2+ -mobilizing agents, the stimulatory effect of embelin on l-citrulline formation (∼4-fold) was substantially lower than that observed upon activation of eNOS with the Ca 2+ ionophore A23187 (∼18-fold), the receptor agonist ATP (∼16-fold) or the sarco-endoplasmic reticulum Ca 2+ -ATPase inhibitor thapsigargin (∼14-fold). The apparent discrepancy between NO/cGMP and l-citrulline formation in embelin-treated cells was not due to enhanced metabolism and/or efflux of l-citrulline, increased NO bioavailability, inhibition of cGMP hydrolysis, sensitization of soluble guanylate cyclase (sGC) to NO, or enhanced formation of a sGC/eNOS complex. Our puzzling observations suggest that embelin improves coupling of endothelial NO synthesis to sGC activation through mobilization of an as yet unrecognized signaling pathway.",
keywords = "Embelin, Endothelial nitric oxide synthase, Nitric oxide, Soluble guanylate cyclase, cGMP, l-Citrulline",
author = "Kurt Schmidt and Jens Martens-Lobenhoffer and Andreas Meinitzer and Graier, {Wolfgang F.} and Torres, {Christina M.} and Venema, {Richard C} and Bernd Mayer",
year = "2010",
month = "5",
day = "15",
doi = "10.1016/j.niox.2010.02.001",
language = "English (US)",
volume = "22",
pages = "281--289",
journal = "Nitric Oxide - Biology and Chemistry",
issn = "1089-8603",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin

T2 - Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and l-citrulline formation

AU - Schmidt, Kurt

AU - Martens-Lobenhoffer, Jens

AU - Meinitzer, Andreas

AU - Graier, Wolfgang F.

AU - Torres, Christina M.

AU - Venema, Richard C

AU - Mayer, Bernd

PY - 2010/5/15

Y1 - 2010/5/15

N2 - The benzoquinone derivative embelin is a multifunctional drug that not only induces apoptosis by inhibiting XIAP, the X chromosome-linked inhibitor of apoptosis protein, but also blocks nuclear factor-κB signaling pathways, thereby leading to down-regulation of a variety of gene products involved in tumor cell survival, proliferation, invasion, angiogenesis, and inflammation. Here, we report that embelin activates and modulates l-arginine/nitric oxide/cyclic GMP signaling in cultured endothelial cells. Embelin elicited a rapid increase of intracellular free Ca 2+ , leading to activation of endothelial nitric oxide synthase (eNOS) and NO-induced cGMP accumulation. While the cGMP response was comparable to that caused by other Ca 2+ -mobilizing agents, the stimulatory effect of embelin on l-citrulline formation (∼4-fold) was substantially lower than that observed upon activation of eNOS with the Ca 2+ ionophore A23187 (∼18-fold), the receptor agonist ATP (∼16-fold) or the sarco-endoplasmic reticulum Ca 2+ -ATPase inhibitor thapsigargin (∼14-fold). The apparent discrepancy between NO/cGMP and l-citrulline formation in embelin-treated cells was not due to enhanced metabolism and/or efflux of l-citrulline, increased NO bioavailability, inhibition of cGMP hydrolysis, sensitization of soluble guanylate cyclase (sGC) to NO, or enhanced formation of a sGC/eNOS complex. Our puzzling observations suggest that embelin improves coupling of endothelial NO synthesis to sGC activation through mobilization of an as yet unrecognized signaling pathway.

AB - The benzoquinone derivative embelin is a multifunctional drug that not only induces apoptosis by inhibiting XIAP, the X chromosome-linked inhibitor of apoptosis protein, but also blocks nuclear factor-κB signaling pathways, thereby leading to down-regulation of a variety of gene products involved in tumor cell survival, proliferation, invasion, angiogenesis, and inflammation. Here, we report that embelin activates and modulates l-arginine/nitric oxide/cyclic GMP signaling in cultured endothelial cells. Embelin elicited a rapid increase of intracellular free Ca 2+ , leading to activation of endothelial nitric oxide synthase (eNOS) and NO-induced cGMP accumulation. While the cGMP response was comparable to that caused by other Ca 2+ -mobilizing agents, the stimulatory effect of embelin on l-citrulline formation (∼4-fold) was substantially lower than that observed upon activation of eNOS with the Ca 2+ ionophore A23187 (∼18-fold), the receptor agonist ATP (∼16-fold) or the sarco-endoplasmic reticulum Ca 2+ -ATPase inhibitor thapsigargin (∼14-fold). The apparent discrepancy between NO/cGMP and l-citrulline formation in embelin-treated cells was not due to enhanced metabolism and/or efflux of l-citrulline, increased NO bioavailability, inhibition of cGMP hydrolysis, sensitization of soluble guanylate cyclase (sGC) to NO, or enhanced formation of a sGC/eNOS complex. Our puzzling observations suggest that embelin improves coupling of endothelial NO synthesis to sGC activation through mobilization of an as yet unrecognized signaling pathway.

KW - Embelin

KW - Endothelial nitric oxide synthase

KW - Nitric oxide

KW - Soluble guanylate cyclase

KW - cGMP

KW - l-Citrulline

UR - http://www.scopus.com/inward/record.url?scp=77949915404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949915404&partnerID=8YFLogxK

U2 - 10.1016/j.niox.2010.02.001

DO - 10.1016/j.niox.2010.02.001

M3 - Article

VL - 22

SP - 281

EP - 289

JO - Nitric Oxide - Biology and Chemistry

JF - Nitric Oxide - Biology and Chemistry

SN - 1089-8603

IS - 4

ER -